Daniil Gataulin
Stock Analyst at Chardan Capital
(0)
# 4772
Out of 5,338 analysts
97
Total ratings
22.97%
Success rate
-21.61%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ADVM Adverum Biotechnolog... | Maintains: Buy | 33 33 | 2.04 | 1517.65% | 7 | May 15, 2025 | |
MGTX MeiraGTx Hldgs | Maintains: Buy | 38 35 | 5.02 | 597.21% | 4 | May 14, 2025 | |
CRVO CervoMed | Maintains: Strong Buy | 14 15 | 8.65 | 73.41% | 6 | May 12, 2025 | |
OCGN Ocugen | Maintains: Buy | 7 7 | 0.71 | 885.92% | 11 | May 12, 2025 | |
QURE uniQure | Maintains: Buy | 38 38 | 13.25 | 186.79% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 28 33 | 18.24 | 80.92% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 33 27 | 5.71 | 372.85% | 11 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 4 | 0.32 | 1150% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 70 70 | 15.46 | 352.78% | 2 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 4 | 0.76 | 426.32% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 64 61 | 7.95 | 667.3% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 6 | 0.84 | 614.29% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 52 52 | 8.65 | 501.16% | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 3 3 | 1.68 | 78.57% | 8 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 220 220 | 2.2 | 9900% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 22 13 | n/a | n/a | 2 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Sep 28, 2022 |